Patents by Inventor Yaru LIU

Yaru LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240351921
    Abstract: A method for preventing and treating pollution plume migration of a permeable reactive barrier including: mounting monitoring assemblies, so as to monitor operation parameters of an active filler in a reactive barrier and a downstream water body of the reactive barrier in real time; determining whether the active filler in the reactive barrier is passivated according to a change state of the operation parameters, and if passivation occurs, performing a depassivation treatment on the reactive barrier; determining whether a gas blockage occurs in the active filler in the reactive barrier according to the change state of the operation parameters, and if a gas blockage occurs, performing a gas guiding treatment on the reactive barrier; and determining whether a microorganism content in the reactive barrier is greater than a preset microorganism value according to the change state of the operation parameters.
    Type: Application
    Filed: June 28, 2024
    Publication date: October 24, 2024
    Applicant: BCEG ENVIRONMENT REMEDIATION CO., LTD
    Inventors: Lili GUO, Shupeng LI, Jiachen LI, Yaru LIU, Jiaming ZHANG, Shaoguo KANG, Hongwei XU, Jing XIONG, Qi WANG
  • Publication number: 20240267275
    Abstract: An information mapping method includes mapping, by a transmitting end device, first information to second information on a delay-Doppler frame. The delay-Doppler frame includes M×N grids, M is the total number of delay indexes, N is the total number of Doppler indexes. The delay-Doppler frame includes at least two subframes, and each subframe includes a first guard interval portion, a first mapping portion, and two second mapping portions. The two second mapping portions occupy grids corresponding to kmax Doppler indexes at a head and a tail of the subframe in a Doppler direction, and the first mapping portion occupies grids corresponding to (N/G?2kmax) Doppler indexes of the subframe; G being the number of subframes in the delay-Doppler frame. Information mapped to second mapping portions at heads of different subframes is the same, and information mapped to second mapping portions at tails of different subframes is the same.
    Type: Application
    Filed: April 12, 2024
    Publication date: August 8, 2024
    Inventors: Fanggang Wang, Dong Wang, Bule Sun, Hao Liu, Pu Yuan, Xiran Li, Yaru Shan, Yaxing Hao
  • Publication number: 20240255413
    Abstract: The present disclosure provides a field integrated device for automatically shielding and collecting rainwater and simulating rainfall and an experimental method. The field integrated device comprises a roller shutter assembly. A rainfall assembly and a rainwater collecting assembly are fixed on the roller shutter assembly. The roller shutter assembly guides rainwater into the rainwater collecting assembly while shielding the rainwater. The rainfall assembly is connected with a pumping assembly. The pumping assembly transports the rainwater to the rainfall assembly to realize artificial rainfall simulation. The pumping assembly is fixed in a solar module. The solar module is electrically connected with the pumping assembly and a driving assembly in the roller shutter assembly. The solar module is in signal connection with a remote signal end.
    Type: Application
    Filed: May 5, 2023
    Publication date: August 1, 2024
    Applicant: China Institute of Water Resources and Hydropower Research
    Inventors: Yifan SONG, Xiaogang WANG, Tianling QIN, Yajing LU, Denghua YAN, Tiejun LIU, Jianan YAO, Rui JIAO, Yumei TAN, Baisha WENG, Yaru FENG, Xiaojie YANG
  • Publication number: 20240247060
    Abstract: The present invention relates to specific CLDN18.2 binding molecules, and an immunoconjugate and a composition containing the CLDN18.2 binding molecules. The present invention further relates to a nucleic acid encoding the CLDN18.2 binding molecules, a host cell containing same, and a method for preparing the CLDN18.2 binding molecules. Furthermore, the present invention relates to the therapeutic and diagnostic use of the CLDN18.2 binding molecules. In particular, the present invention relates to the combined treatment of the CLDN18.2 binding molecules with other therapies, such as a therapeutic method or a therapeutic agent.
    Type: Application
    Filed: July 13, 2022
    Publication date: July 25, 2024
    Inventors: Xintian YAN, Guojun LANG, Yongcong TAN, Chanjuan LIU, Chao KONG, Run YAN, Yaru LIU, Tianen YAO